n,n-dimethylarginine has been researched along with Cardiomyopathy, Dilated in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Burger, AL; Demyanets, S; Diedrich, A; Pezawas, T; Stojkovic, S; Wojta, J | 1 |
Anderssohn, M; Böger, RH; Frey, N; Lüneburg, N; Lutz, M; Rosenberg, M; Schwedhelm, E; Zugck, C | 1 |
2 other study(ies) available for n,n-dimethylarginine and Cardiomyopathy, Dilated
Article | Year |
---|---|
Elevated plasma levels of asymmetric dimethylarginine and the risk for arrhythmic death in ischemic and non-ischemic, dilated cardiomyopathy - A prospective, controlled long-term study.
Topics: Aged; Arginine; Arrhythmias, Cardiac; Cardiomyopathy, Dilated; Case-Control Studies; Female; Heart Arrest; Humans; Male; Middle Aged; Myocardial Ischemia; Prospective Studies; Risk Factors; Ventricular Dysfunction, Left | 2020 |
The L-Arginine-asymmetric dimethylarginine ratio is an independent predictor of mortality in dilated cardiomyopathy.
Topics: Arginine; Biomarkers; Cardiomyopathies; Cardiomyopathy, Dilated; Chromatography, Liquid; Creatinine; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Myocardial Ischemia; Natriuretic Peptide, Brain; Peptide Fragments; Severity of Illness Index; Tandem Mass Spectrometry | 2012 |